Викстицибарт

Prop. INN (наименование, предложенное ВОЗ)

immunoglobulin G4-kappa, anti-[Homo sapiens NPR1 (natriuretic peptide receptor 1, natriuretic peptide receptor A, NPRA, atrionatriuretic peptide receptor A, ANPRA, guanylate cyclase A, GUCY2A)], Homo sapiens monoclonal antibody, agonist;
H-gamma4 heavy chain Homo sapiens (1-451) [VH (Homo sapiens IGHV1-2*02 (91.8%) -(IGHD) -IGHJ6*01 (100%), CDR-IMGT [8.8.17] (26-33.51-58.97-113)) (1-124) -Homo sapiens IGHG4*01, nG4m(a) CH2 L92, G4v5 h P10 (CH1 (125-222), hinge 1-12 S10>P (232) (223-234), CH2 L92 (313) (235-344), CH3 (345-449), CHS (450-451)) (125-451)], (138-213')-disulfide with L-kappa light chain Homo sapiens (1'-213') [V-KAPPA (Homo sapiens IGKV1-39*01 (94.7%) -IGKJ5*02 (100%), CDR-IMGT [6.3.8] (27'-32'.50'-52'.89'-96')) (1'-106') -Homo sapiens IGKC*01 (100%), Km3 A45.1 (152'), V101 (190') (107'-113')]; dimer (230-230'':233-233'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-K1, glycoform alfa

Поделиться этой страницей